Sunho Biologics Invests in Secure Funds

Sunho Biologics,Inc. (HK:2898) has released an update.

Sunho Biologics, Inc. has announced the subscription of funds in three principal-and-return-guaranteed investments, totaling USD 22.52 million, with an anticipated annual return rate of 6% for each. These investments include short-term, high-quality monetary market instruments and allow for voluntary redemption by Sunho HK. The move is aimed at effective treasury management using the company’s internal resources, excluding proceeds from their global offering.

For further insights into HK:2898 stock, check out TipRanks’ Stock Analysis page.